A life-changing journey awaits us as we delve into the story of Jaci Van Altena, a brave individual who battled a rare form of blood cancer. But here's the twist: her treatment involved a groundbreaking procedure, one that sparked both hope and controversy.
Jaci, a former Canadian navy member, found herself in New Zealand, working on a flower farm, when her health took an unexpected turn. She experienced symptoms that left her concerned, and after seeking medical help, she received a shocking diagnosis: Acute Lymphoblastic Leukemia, a rapidly progressing blood cancer.
The Road to Treatment
Originally from Bayfield, Ontario, Jaci's closest treatment option was the Verspeeten Family Cancer Centre at London Health Sciences Centre (LHSC). The centre's expertise in blood and marrow transplants offered a glimmer of hope.
"My New Zealand team connected with the Verspeeten, and we began a long-distance dialogue until I could return to Canada for treatment," Jaci shared.
After trying various treatments, Jaci was referred to the Blood and Marrow Transplant Program (BMTP) at the Verspeeten. Here's where it gets controversial: the standard treatment for her cancer was a stem cell transplant, but with a unique twist - an unrelated donor.
Unrelated Donor Stem Cell Transplant: A New Frontier
The unrelated donor stem cell transplant program at LHSC was a recent development, launched in May 2025. Jaci became the program's first recipient of an unrelated donor transplant during the summer of that year.
Carey Landry, Director of Inpatient Oncology at LHSC, explained, "Related donor stem cell transplants have been performed for years, but unrelated donor transplants are more complex. They require international coordination, rigorous donor screening, and adherence to global standards."
The process began with Jaci's care team searching for potential donors through the Canadian Blood Services' Stem Cell Registry. The results are based on genetic matching, and donors can be from anywhere in the world. The BMTP team ensures that only compliant registries are used, maintaining high standards of quality and disease transmission control.
The team usually identifies one primary donor and, if possible, a backup. This ensures that any last-minute donor issues don't delay the transplant.
Once a donor is chosen, the collection date is set, and a courier is arranged to deliver the stem cells to the Verspeeten.
"Everything hinged on the donor's availability. Once they donated, their stem cells were transported to the Verspeeten, and I received them through my Hickman line," Jaci explained.
The Transplant: A Challenging Ride
Despite her familiarity with the process, Jaci faced more challenges than she anticipated. "I handled chemotherapy well, so I thought the transplant would be a breeze. But I had severe mouth sores and lost my appetite, relying on food through my Hickman line. I felt weak and lost muscle mass. It was tougher than I expected."
Despite the difficulties, Jaci remained optimistic and praised her care team.
"The nurses on the seventh floor were incredible. They understood my sense of humor, and we had a great time together. I'm forever grateful to my team," she shared.
Life After Transplant
Jaci is doing remarkably well now and continues to be monitored by Dr. Uday Deotare, her stem cell transplant physician. She's taking things one day at a time, gradually returning to her normal life.
"I'm back at work a few hours a day with my dad in construction. I'm hitting the gym to regain my strength, and I'm eating healthily. I'm ready for the next chapter," she said.
As we reflect on Jaci's journey, it's clear that her story is a testament to the power of modern medicine and the resilience of the human spirit. But it also raises questions: Is the use of unrelated donors a viable long-term solution? What are the ethical considerations? And how can we ensure the best outcomes for patients like Jaci?
What are your thoughts? Feel free to share your opinions and experiences in the comments below.
